Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans
Bonner, G.; Preis, S.; Schunk, U.; Toussaint, C.; Kaufmann, W. Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J. Cardiovasc. Pharmacol. 15(6):S46-56; 1990.
Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels
Johnston, C. I.; Clappison, B. H.; Anderson, W. P.; Yasujima, M. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am. J. Cardiol. 49(6):1401-1404; 1982.
Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations
Lembeck, F.; Griesbacher, T.; Eckhardt, M. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations. Br. J. Pharmacol. 100(1):49-54; 1990.
Effect of Neurotropin on the activation of the plasma kallikrein-kinin system
Nishikawa, K.; Reddigari, S. R.; Silverberg, M.; Kuna, P. B.; Yago, H.; Nagaki, Y.; Toyomaki, Y.; Suehiro, S.; Kaplan, A. P. Effect of Neurotropin on the activation of the plasma kallikrein-kinin system. Biochem. Pharmacol. 43(6):1361-1369; 1992.
A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochem
Yang, H. Y. T.; Erdos, E. G.; Levin, Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochem. Biophys. Acta. 214:211-234; 1970.